The Rising Role of Modeling in Oncology - From Translation to Confirmation

 

Preliminary Pre-Conference Program

 

 

 
ACoP11 Pre-Conference: The Rising Role of Modeling in Oncology - From Translation to Confirmation (separate registration required)
 Co-Chairs: Heather Vezina (BMS), Peter Bonate (Astellas) and Mary Spilker (Pfizer)
  
Continental Breakfast and Registration
 
 Welcome/Conference Highlights/Conference Rating Importance  Mary Spilker (Pfizer)
 
Keynote Lecture 
  
Current Modeling Practices
Translation in Oncology: Current Practices & Impact Owen Jones (Astra Zeneca)
Tumor Growth Dynamic Modeling Rene Bruno (Genentech/Roche)
Mathematical Oncology Kristin Swanson (Arizona State University)
  
Emerging Modeling Approaches
MBMA Marion Bouillon-Pichault (BMS)
QSP Modeling & -Omics Data Andrzej Kierzek (Certara)
   
Model Informed Drug Development (MIDD) in Oncology
Overview of MIDD Pilot Program Rajanikanth Madabushi (FDA)
Sponsor case examples  
   

Session A: Translational: Animal Model vs. In Silico Approaches

 Moderator: Mary Spilker (Pfizer)
Session B: Clinical: Best Practices in Exposure-Response Analysis Peter Bonate (Astellas), Ana Ruiz (Metrum Research Group)
Parallel Sessions Debrief and Panel Discussion  
   
 Closing remarks & Preview of ACoP11   Heather Vezina (BMS)